| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Adipocytokines in synovial fluid.
|
JAMA
|
2003
|
2.48
|
|
2
|
C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue.
|
Endocrinology
|
2010
|
2.11
|
|
3
|
Different effects of adiponectin isoforms in human monocytic cells.
|
J Leukoc Biol
|
2006
|
1.74
|
|
4
|
The potential of adiponectin in driving arthritis.
|
J Immunol
|
2006
|
1.70
|
|
5
|
Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes.
|
Clin Endocrinol (Oxf)
|
2009
|
1.57
|
|
6
|
Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal.
|
J Gastroenterol Hepatol
|
2008
|
1.56
|
|
7
|
Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.
|
Clin Cancer Res
|
2009
|
1.38
|
|
8
|
Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes.
|
Obesity (Silver Spring)
|
2009
|
1.24
|
|
9
|
Adiponectin isoforms: a potential therapeutic target in rheumatoid arthritis?
|
Ann Rheum Dis
|
2012
|
1.20
|
|
10
|
The adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cells.
|
FEBS Lett
|
2005
|
1.19
|
|
11
|
Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis.
|
Arthritis Rheum
|
2010
|
1.17
|
|
12
|
Profiling adipocytokine secretion from creeping fat in Crohn's disease.
|
Inflamm Bowel Dis
|
2006
|
1.15
|
|
13
|
Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release.
|
Biochem Biophys Res Commun
|
2007
|
1.13
|
|
14
|
Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes.
|
J Clin Endocrinol Metab
|
2010
|
1.13
|
|
15
|
Effects of the new adiponectin paralogous protein CTRP-3 and of LPS on cytokine release from monocytes of patients with type 2 diabetes mellitus.
|
Cytokine
|
2009
|
1.13
|
|
16
|
Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease.
|
Inflamm Bowel Dis
|
2010
|
1.11
|
|
17
|
Therapeutic management of pyoderma gangrenosum.
|
Arthritis Rheum
|
2004
|
1.10
|
|
18
|
C1q/TNF-related protein-3 (CTRP-3) is secreted by visceral adipose tissue and exerts antiinflammatory and antifibrotic effects in primary human colonic fibroblasts.
|
Inflamm Bowel Dis
|
2011
|
1.00
|
|
19
|
In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1).
|
J Clin Endocrinol Metab
|
2011
|
0.96
|
|
20
|
Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors.
|
Biochem Biophys Res Commun
|
2005
|
0.95
|
|
21
|
Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathways.
|
Am J Physiol Gastrointest Liver Physiol
|
2009
|
0.95
|
|
22
|
Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro.
|
Biochem Biophys Res Commun
|
2006
|
0.95
|
|
23
|
Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes.
|
Endocrinology
|
2010
|
0.95
|
|
24
|
Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis.
|
Cytokine
|
2010
|
0.95
|
|
25
|
Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol.
|
Oncol Rep
|
2008
|
0.94
|
|
26
|
Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release.
|
FEBS Lett
|
2008
|
0.94
|
|
27
|
Detection of adiponectin in cerebrospinal fluid in humans.
|
Am J Physiol Endocrinol Metab
|
2007
|
0.94
|
|
28
|
Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes.
|
FEBS Lett
|
2008
|
0.94
|
|
29
|
Effects of the new C1q/TNF-related protein (CTRP-3) "cartonectin" on the adipocytic secretion of adipokines.
|
Obesity (Silver Spring)
|
2008
|
0.94
|
|
30
|
Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis.
|
World J Gastroenterol
|
2006
|
0.90
|
|
31
|
Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3.
|
Endocrinology
|
2010
|
0.89
|
|
32
|
Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetes.
|
Cytokine
|
2009
|
0.87
|
|
33
|
Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes.
|
Cardiovasc Diabetol
|
2006
|
0.87
|
|
34
|
MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis.
|
Exp Mol Pathol
|
2011
|
0.85
|
|
35
|
Bile acid signaling after an oral glucose tolerance test.
|
Chem Phys Lipids
|
2011
|
0.85
|
|
36
|
Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis.
|
Exp Mol Pathol
|
2011
|
0.84
|
|
37
|
Lipopolysaccharide regulated protein expression is only partly impaired in monocytes from patients with type I diabetes.
|
Cardiovasc Diabetol
|
2006
|
0.83
|
|
38
|
Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes.
|
FEBS Lett
|
2011
|
0.83
|
|
39
|
Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver.
|
Mol Cell Endocrinol
|
2011
|
0.83
|
|
40
|
Metformin reduces cellular lysophosphatidylcholine and thereby may lower apolipoprotein B secretion in primary human hepatocytes.
|
Biochim Biophys Acta
|
2008
|
0.83
|
|
41
|
Splanchnic concentrations and postprandial release of visceral adipokines.
|
Metabolism
|
2009
|
0.83
|
|
42
|
Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults.
|
Cardiovasc Diabetol
|
2007
|
0.82
|
|
43
|
Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis.
|
Exp Mol Pathol
|
2011
|
0.82
|
|
44
|
Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes.
|
Biochim Biophys Acta
|
2010
|
0.82
|
|
45
|
Intracellular survival of Staphylococcus aureus in adipocyte-like differentiated 3T3-L1 cells is glucose dependent and alters cytokine, chemokine, and adipokine secretion.
|
Endocrinology
|
2011
|
0.81
|
|
46
|
Low-abundant adiponectin receptors in visceral adipose tissue of humans and rats are further reduced in diabetic animals.
|
Arch Med Res
|
2010
|
0.81
|
|
47
|
Insulin induces monocytic CXCL8 secretion by the mitogenic signalling pathway.
|
Cytokine
|
2008
|
0.80
|
|
48
|
Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.
|
Cytokine
|
2011
|
0.79
|
|
49
|
The role of domestic hygiene in inflammatory bowel diseases: hepatitis A and worm infestations.
|
Eur J Gastroenterol Hepatol
|
2008
|
0.79
|
|
50
|
Systemic resistin is increased in type 2 diabetic patients treated with loop diuretics.
|
J Diabetes Complications
|
2011
|
0.78
|
|
51
|
Adiponectin downregulates galectin-3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes.
|
FEBS Lett
|
2009
|
0.78
|
|
52
|
Highly efficient and low-cost method to isolate human blood monocytes with high purity.
|
J Immunol Methods
|
2008
|
0.78
|
|
53
|
Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function.
|
Cytokine
|
2011
|
0.77
|
|
54
|
Elevated free fatty acids and impaired adiponectin bioactivity contribute to reduced SOD2 protein in monocytes of type 2 diabetes patients.
|
Exp Mol Pathol
|
2010
|
0.77
|
|
55
|
Admission levels of soluble CD137 are increased in patients with acute pancreatitis and are associated with subsequent complications.
|
Exp Mol Pathol
|
2011
|
0.76
|
|
56
|
Papillary thyroid cancer associated with syndrome of inappropriate antidiuresis: a case report.
|
J Med Case Rep
|
2010
|
0.75
|
|
57
|
[Candidate genes and polymorphism analysis in type 2 diabetes mellitus].
|
Med Klin (Munich)
|
2006
|
0.75
|
|
58
|
[Reversible metabolic syndrome].
|
Med Klin (Munich)
|
2008
|
0.75
|
|
59
|
Portal levels of latent transforming growth factor-β are related to liver function in patients with liver cirrhosis.
|
Eur J Gastroenterol Hepatol
|
2011
|
0.75
|
|
60
|
[Hormone-induced spontaneous femoral neck fracture in a 28-year-old female patient].
|
Med Klin (Munich)
|
2009
|
0.75
|
|
61
|
Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro.
|
Exp Mol Pathol
|
2011
|
0.75
|